-
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis
Driessen, J., de Wit, F., Herrera, A. F., Zinzani, P. L., LaCasce, A. S., Cole, P. D., Moskowitz, C. H., García-Sanz, R., Fuchs, M., Müller, H., Borchmann, P., Santoro, A., Schöder, H., Zijlstra, J. M., Hutten, B. A., Moskowitz, A. J. & Kersten, M. J., 11 Jun 2024, In: Blood. 8, 11, p. 2740-2752 13 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications